Dapagliflozin Effect on FunctiOnal Mitral Regurgitation and Myocardial Fibrosis (DEFORM)
Condition: Functional Mitral Regurgitation Intervention: Drug: dapagliflozin Sponsors: Sun Yat-sen University; First Affiliated Hospital, Sun Yat-Sen University; Third Affiliated Hospital, Sun Yat-Sen University; Second Affiliated Hospital of Guangzhou Medical University; Jieyang People's Hospital; Eighth Affiliated Hospital, Sun Yat-sen University; Affiliated Hospital of Guangdong Medical University; Yuebei People's Hospital; Zhongshan People's Hospital, Guangdong, China Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 8, 2023 Category: Research Source Type: clinical trials
Dapagliflozin in Non Alcoholic Fatty Liver Disease Associated Cirrhosis and Its Role in Preventing Development of Chronic Kidney Disease.
Condition: NAFLD Cirrhosis Interventions: Drug: Dapagliflozin; Other: Standard of Care Sponsor: Institute of Liver and Biliary Sciences, India Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 8, 2023 Category: Research Source Type: clinical trials
Polypill Versus Metformin in New Onset Type 2 Diabetes
Condition: Type 2 Diabetes Interventions: Drug: GMRx4 polypill - sitagliptin, dapagliflozin, metformin; Drug: Metformin Sponsors: George Medicines PTY Limited; MRCF Pty Ltd; The George Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 27, 2023 Category: Research Source Type: clinical trials
Dapagliflozin Evaluation on Atrial Fibrillation Patients Followed Cox Maze IV Procedure
Conditions: Atrial Fibrillation Recurrence; Cox Maze IV; Atrial Fibrillation; Patients With or Without Heart Failure and Diabetes Interventions: Drug: Dapagliflozin; Drug: Placebo Sponsor: Kun Hua Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2023 Category: Research Source Type: clinical trials
